BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma ; volume:22 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-19 ; date:12.2024
Journal of nanobiotechnology ; 22, Heft 1 (23.5.2024), 1-19, 12.2024
- Creator
-
Lu, Qizhong
Li, Hexian
Wu, Zhiguo
Zhu, Zhixiong
Zhang, Zongliang
Yang, Donghui
Tong, Aiping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-024-02512-6
- URN
-
urn:nbn:de:101:1-2408020908341.833215344244
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lu, Qizhong
- Li, Hexian
- Wu, Zhiguo
- Zhu, Zhixiong
- Zhang, Zongliang
- Yang, Donghui
- Tong, Aiping
- SpringerLink (Online service)
Other Objects (12)
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile